| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/17/2008 | WO2008008493A2 Alkyne-substituted pyridone compounds and methods of use |
| 01/17/2008 | WO2008008327A2 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008007099A1 A pharmaceutical formulation comprising a beta2-selective adrenorezeptor agonist and / or glucocorticoid and method for the preparation thereof |
| 01/17/2008 | WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | WO2008006563A1 Purine derivatives as a2a agonists |
| 01/17/2008 | WO2008006509A1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| 01/17/2008 | WO2008006295A1 New optical active phenylethanol amines and preparing method thereof |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2006137789A8 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015243 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 01/17/2008 | US20080015240 Acid Salt of Benzimidazole Derivative and Crystal Thereof |
| 01/17/2008 | US20080015226 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors |
| 01/17/2008 | US20080015222 New Heterocyclic Amides |
| 01/17/2008 | US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080014201 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080011293 Stable Xylometazoline and Oxymetazoline Solution |
| 01/17/2008 | DE102006031813A1 Basische Acetophenone als Hemmstoffe von NO-Synthasen Basic acetophenones as inhibitors of NO synthases |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2657902A1 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 01/17/2008 | CA2657227A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | CA2656012A1 Purine derivatives as a2a agonists |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878722A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/16/2008 | EP1878664A1 Process for producing metered dose inhaler formulations |
| 01/16/2008 | EP1878436A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 01/16/2008 | EP1877434A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 01/16/2008 | EP1625126B1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 01/16/2008 | EP1542904B1 Process for producing metered dose inhaler formulations |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | CN201006019Y Asthma eliminating Sanshu ointment |
| 01/16/2008 | CN101107249A Purine derivatives acting as a2a receptor agonists |
| 01/16/2008 | CN101107226A Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 01/16/2008 | CN101107005A CRIg polypeptide for prevention and treatment of complement-associated disorders |
| 01/16/2008 | CN101104074A Orally taken traditional Chinese medicine for treating cold syndrome type asthma in children |
| 01/16/2008 | CN101104073A Method for preparing traditional Chinese medicine dropping for treating rhinitis |
| 01/16/2008 | CN101104070A Orally taken traditional Chinese medicine for treating chest distress type asthma |
| 01/16/2008 | CN101104065A Traditional Chinese medicine preparation for preventing respiratory viral infection disease and preparation method |
| 01/16/2008 | CN101104064A Traditional Chinese medicine specially used for treating fishbone blocking throat |
| 01/16/2008 | CN101104061A Decoction medicine for treating exterior-cold lung-attacked type pertussis and preparation method |
| 01/16/2008 | CN101104060A Traditional Chinese medicine formula for treating acute and chronic bronchitis (asthma) |
| 01/16/2008 | CN101104056A Medicine for treating lung carbuncle and its preparation method |
| 01/16/2008 | CN101104055A Internal-applied traditional Chinese medicine for treating common cold |
| 01/16/2008 | CN101104053A Decoction medicine for treating liver qi stagnancy type pharyngitis and preparation method |
| 01/16/2008 | CN101104052A Decoction medicine for treating hyperactivity of liver-yang type pharyngitis and preparation method |
| 01/16/2008 | CN101104051A Decoction medicine for treating yin deficiency type pharyngitis and preparation method |
| 01/16/2008 | CN101104050A Decoction medicine for treating liver-fire attacking lung type pharyngitis and preparation method |
| 01/16/2008 | CN101104049A Decoction medicine for treating pharyngitis and preparation method |
| 01/16/2008 | CN101104040A Decoction medicine for treating phlegm-turbidity-in-lung type pharyngitis and preparation method |
| 01/16/2008 | CN101104039A Internal-applied traditional Chinese medicine for treating abundant-phlegm type child asthma |
| 01/16/2008 | CN101104037A Internal-applied traditional Chinese medicine for treating damp-heat type child asthma |
| 01/16/2008 | CN101104034A Internal-applied traditional Chinese medicine for treating phlegm-stagnation type asthma |
| 01/16/2008 | CN101104032A Decoction medicine for treating damp-heat type pharyngitis and preparation method |
| 01/16/2008 | CN101104031A Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer |
| 01/16/2008 | CN101104027A Cough-relieving traditional Chinese medicine micropill preparation and preparation method thereof |
| 01/16/2008 | CN101104026A Decoction medicine for treating phlegm-heat lung-damage type pertussis and preparation method |
| 01/16/2008 | CN101104025A Decoction medicine for treating cough caused by long-lasting diseases and preparation method |
| 01/16/2008 | CN101104021A Decoction medicine for treating blood-heat type pharyngitis and preparation method |
| 01/16/2008 | CN101104007A Application of taxus leaf in preparing medicinal liquid for treating laryngopharyngitis |
| 01/16/2008 | CN101103980A Fexofenadine medicinal composition |
| 01/16/2008 | CN101103968A Ambroxol oral liquid with good taste |
| 01/16/2008 | CN101103963A Levalbuterol hydrochloride orally disintegrating tablet and preparation method thereof |
| 01/16/2008 | CN100362008C Barbat skullcap general flavone preparation method and quality control method |
| 01/16/2008 | CN100361975C Novel 5-hydroxy-3-carboxylate indoles derivant and method for preparing the same |
| 01/16/2008 | CN100361699C Medicine for treating common cold and its preparing method |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7318436 Medicament container with same side airflow inlet and outlet and method of use |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/10/2008 | WO2008004948A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 01/10/2008 | WO2008003978A2 Dioxo-alkanes and dioxo-alkenes |
| 01/10/2008 | WO2008003748A2 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 01/10/2008 | WO2008003612A2 Analogs of vasoactive intestinal peptide |
| 01/10/2008 | WO2008003319A1 Cd20 binding molecules for the treatment of copd |
| 01/10/2008 | WO2008003185A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | WO2007135080A3 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them |
| 01/10/2008 | WO2007125501A3 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness |
| 01/10/2008 | WO2007121921A3 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/10/2008 | WO2007109686A3 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto |
| 01/10/2008 | US20080009535 Inhibitors of phosphodiesterase type-IV |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |